Related Experiment Video
Updated: May 14, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
[Psychiatry]
P Conus1, J-N Despland, F Herrera
1Service de psychiatrie générale, Département de psychiatrie, CHUV, Site de Cery, Prilly. philippe.conus@chuv.ch
Revue Medicale Suisse
|February 2, 2013
Summary
This paper explores a brief psychodynamic approach for major depression, an atypical neuroleptic depot medication, and the scientific reassessment of electroconvulsive therapy for psychiatric treatment.
Area of Science:
- Psychiatry
- Neuroscience
- Psychotherapy
Background:
- Contemporary psychiatry integrates diverse therapeutic modalities.
- Hospitalized patients with major depression require effective treatment strategies.
- The historical misuse of electroconvulsive therapy necessitates a data-driven re-evaluation.
Purpose of the Study:
- To describe a novel brief psychodynamic therapy for hospitalized major depression patients.
- To discuss the commercialization of a new atypical neuroleptic depot medication.
- To objectively assess electroconvulsive therapy based on current scientific evidence.
Main Methods:
- Development and description of a brief psychodynamic intervention.
- Review of recent advancements in atypical neuroleptic depot medication.
- Analysis of scientific data regarding electroconvulsive therapy efficacy and safety.
Main Results:
- A brief psychodynamic approach has been developed for hospitalized patients.
- A new atypical neuroleptic depot medication is now commercially available.
- Recent research suggests electroconvulsive therapy can be a valuable tool in specific contexts.
Conclusions:
- Psychiatric treatment benefits from a multi-faceted approach.
- Innovations in pharmacotherapy and psychotherapy offer new options for major depression.
- Objective evaluation of electroconvulsive therapy, despite historical concerns, is warranted based on scientific data.
Related Concept Videos
01:30Psychosurgery
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:29Psychodynamic Therapy
Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...